Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny L Moore

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Science (New York, N.Y.)|December 1, 2022
Triggering rare HIV antibodies by vaccinationPenny L Moore
Current HIV Research|November 28, 2017
The Neutralizing Antibody Response to the HIV-1 Env ProteinPenny L Moore
The Lancet. Infectious Diseases|October 26, 2023
Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccinesAlexandra Trkola, Penny L Moore
Retrovirology|September 7, 2018
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizersElise Landais, Penny L Moore
Current Opinion in HIV and AIDS|August 26, 2016
Approaches to the induction of HIV broadly neutralizing antibodiesPenny L Moore, Carolyn Williamson
Cell Host & Microbe|June 15, 2023
COVID-19 as a catalyst for vaccine manufacturing: A South African experiencePenny L Moore, Glenda Gray
Current Opinion in HIV and AIDS|April 30, 2019
The antibody response in HIV-1-infected donorsSimone I Richardson, Penny L Moore
Immunity|May 18, 2017
Size Doesn't Matter: Shorter Antibody Loops Can Infiltrate HIV's Env Apex DefensesJinal N Bhiman, Penny L Moore
Expert Opinion on Therapeutic Targets|March 23, 2021
Targeting Fc effector function in vaccine designSimone I Richardson, Penny L Moore
Immunological Reviews|May 22, 2022
Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concernJinal N Bhiman, Penny L Moore
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Science (New York, N.Y.)|December 1, 2022
Triggering rare HIV antibodies by vaccinationPenny L Moore
Current HIV Research|November 28, 2017
The Neutralizing Antibody Response to the HIV-1 Env ProteinPenny L Moore
The Lancet. Infectious Diseases|October 26, 2023
Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccinesAlexandra Trkola, Penny L Moore
Retrovirology|September 7, 2018
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizersElise Landais, Penny L Moore
Current Opinion in HIV and AIDS|August 26, 2016
Approaches to the induction of HIV broadly neutralizing antibodiesPenny L Moore, Carolyn Williamson
Cell Host & Microbe|June 15, 2023
COVID-19 as a catalyst for vaccine manufacturing: A South African experiencePenny L Moore, Glenda Gray
Current Opinion in HIV and AIDS|April 30, 2019
The antibody response in HIV-1-infected donorsSimone I Richardson, Penny L Moore
Immunity|May 18, 2017
Size Doesn't Matter: Shorter Antibody Loops Can Infiltrate HIV's Env Apex DefensesJinal N Bhiman, Penny L Moore
Expert Opinion on Therapeutic Targets|March 23, 2021
Targeting Fc effector function in vaccine designSimone I Richardson, Penny L Moore
Immunological Reviews|May 22, 2022
Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concernJinal N Bhiman, Penny L Moore
Pageof 22